Peripheral blood mononuclear cells were obtained from healthy volunteer donors who each provided written informed consent for the use of their cells in accordance with the study protocols approved by the Kumamoto University Hospital Review Board (#1169). Monocytes were isolated using
RosettSep cocktail (StemCell Tech., Vancouver, Canada), plated in UpCELL culture plates (CellSeed, Tokyo, Japan), and cultured in 2% human serum, 1 ng/mL granulocyte
macrophage-colony stimulating factor (WAKO, Tokyo, Japan), and 50 ng/mL
macrophage-colony stimulating factor (WAKO) for 7 days to induce macrophage differentiation. Macrophages (2 × 10
5/well) were then seeded on glass coverslips in a 12-well plate and stimulated with interleukin (IL)-10 (#093-04651, 10 ng/mL, WAKO), interferon (IFN)-α (#11200-2, 10 ng/mL, R&D Systems, Minneapolis, MN, USA), IFN-γ (#IFG4001, 10 ng/mL, WAKO), or lipopolysaccharide (LPS) (#
L2654, 100 ng/mL, Sigma, St. Louis, MO, USA) for 1 day. Cells were fixed with 1% paraformaldehyde and then dried once. Cells were blocked with 1% bovine serum albumin and then stained with anti-Maf antibody. Horseradish peroxidase-labeled anti-rabbit immunoglobulin antibody (Nichirei) was used as the secondary antibody, and diaminobenzidine substrate was used for visualization.
Takeya H., Ohnishi K., Shiota T., Saito Y., Fujiwara Y., Yagi T., Kiyozumi Y., Baba Y., Yoshida N., Asano K., Tanaka M., Baba H, & Komohara Y. (2019). Maf expression in human macrophages and lymph node sinus macrophages in patients with esophageal cancer. Journal of Clinical and Experimental Hematopathology : JCEH, 59(3), 112-118.